Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Fluxome and GlycaNova Join Forces on Beta-Glucan Product - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Fluxome and GlycaNova Join Forces on Beta-Glucan Product

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Fluxome A/S, Copenhagen, Denmark, has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a beta-glucan product in the U.S. dietary supplement market.

The final product, Fluxome Beta Glucan, developed by GlycaNova, is a natural beta-glucan product manufactured by fermentation. The product has been subject to a number of clinical trials, which confirm its immune-enhancing effects in humans, according to the companies.

The unique production process enables Fluxome to supply a standardized product with a guaranteed content of completely intact beta-glucan.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters